Comparing nifedipine to placebo for the maintenance tocolysis of preterm...
Date First Received: September 12, 2005
Last Updated: March 21, 2008
Verified by: Stanford University, March 2008
Clinical Trial Phase: N/A | Start Date: November 2001
Overall Status: Completed
Estimated Enrollment: 0
Brief Summary
Official Title: “Nifedipine for the Maintenance Tocolysis of Preterm Labor: Comparison to Placebo in a Prospective, Randomized Double Blind Trial”
Condition Keyword(s):
Intervention(s):
Comparing nifedipine to placebo for the maintenance tocolysis of preterm labor
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Single Group Assignment
Intervention(s) in this Clinical Trial
- Drug: nifedipine
Outcome Measures for this Clinical Trial
Primary Measures
- Achieving 37 weeks gestation
Secondary Measures
- Incidence of recurrent preterm labor
- Neonatal outcomes
Criteria for Participation in this Clinical Trial
Inclusion Criteria:
- arrested preterm labor
Exclusion Criteria:
- ruptured membranes
- fetal distress
- placenta previa
- placental abruption
- maternal medical contraindication to tocolysis
Gender Eligibility for this Clinical Trial: Female
Minimum Age for this Clinical Trial: 18 Years
Maximum Age for this Clinical Trial: N/A
Are Healthy Volunteers Accepted for this Clinical Trial?: No
Clinical Trial Sponsor Information
Lead Sponsor: Stanford University
Overall Clinical Trial Officials and Contacts
Yasser Yehia El-Sayed Principal Investigator Stanford University
Additional Information
Information obtained from ClinicalTrials.gov on December 03, 2008
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00185952
Study ID Number: 76251
ClinicalTrials.gov Identifier: NCT00185952
Health Authority: United States: Institutional Review Board
Clinical Trials Authorship and Review
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
